Risk factors for progression in patients with KDOQI stage 3 Chronic Kidney Disease (PROGRESER study).

Autores de IDIVAL

• 

  Gema Fernández Fresnedo

  Autor

  gema.fernandezf@scsalud.es

Autores ajenos al IDIVAL

• Martínez-Castelao A
• Górriz Teruel JL
• D'Marco L
• Garrigós E
• Espinel Garuz E
• Cigarrán Guldris S
• Coloma JA
• Robles Pérez-Monteoliva NR
• Esteban de la Rosa JR
• Nieto Iglesias LJ
• Ortiz Arduán A
• Navarro-González JF
• PROGRESER study investigators
• GEENDIAB (Spanish Group for the Study of Diabetic Nephropathy)

Abstract

The PROGRESER study is a multicentre, prospective, observational, 3-year follow-up study of a cohort of patients with stage 3 chronic kidney disease (CKD) from different nephrology departments of hospitals in the Spanish healthcare system. The primary study objective was to analyse risk factors for CKD progression, identifying possible differences between patients with and without diabetes mellitus (DM). The secondary objective was to analyse if the cardiovascular risk factors were also associated with CKD progression.

Copyright © 2024. Published by Elsevier España, S.L.U.

Keywords

• Cardiovascular risk, Chronic kidney disease, Diabetes mellitus, Diabetic kidney disease, Enfermedad renal crónica, Progresión, Progression, Riesgo cardiovascular